After putting 44 lip stains through snacking, sipping, and even some smooching, we found three that are just as comfy as they ...

Clearmind Medicine Inc. (Nasdaq: CMND), a clinical-stage biotechnology company pioneering non‑hallucinogenic neuroplastogen‑derived treatments for Alcohol Use Disorder (AUD), addiction, and weight ...

Production managers frequently encounter two persistent technical challenges: drift in the batch-to-batch tactile response and oil floating or breaking during the emulsification and finishing stages.

Expansion brings mining, oil and gas, and biosurfactant formulation expertise together under one roof to speed product development and customer-focused innovation THE WOODLANDS, Texas, July 15, 2026 ...

Materials innovator demonstrates scalable production while expanding applications beyond pallets through injection ...

Clearmind Medicine Inc. (Nasdaq: CMND), a clinical-stage a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation, ...

As teens enter the skincare category earlier than ever, brands like Bubble, Evereden and Sincerely Yours are redefining teen ...

Through predictive modelling, AI supports target identification, prediction of physicochemical properties and formulation strategy selection.

SPTek Eclipse master batches are designed to break down PE and PP materials into CO₂, water, and biomass rather than ...

A new study introduces Centered Daydreaming, allowing Hopfield networks to achieve 100% capacity on highly biased real-world data.

BioAdaptives® Inc. (OTC: BDPT) today outlined the scientific strategy behind its Xcellara™ cellular wellness platform ahead of the August 1, 2026, commercial launch of XcellaraHeart™. The platform ...

AI is already shaping the digital tools farmers use today and the crop protection products they will use in the future, Syngenta reports. Syngenta executives say artificial intelligence (AI) is ...